Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case report
Xiaoyuan He(Tianjin First Center Hospital), Mingfeng Zhao(Nankai University), Hairong Lyu(University of Bristol), Zhengyu Yu(Sichuan University), Xiaomei Zhang(Jilin Agricultural University), Yanyu Jiang(Tianjin First Center Hospital), Xia Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xue Bai(Shanxi University), Juanxia Meng(Nankai University), Yifan Zhao(Unknown)
Cited by 5
Related Papers
Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer
|Journal of Clinical Investigation|2020|210
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149
Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
|Cell Death and Disease|2013|129